Staar Surgical (STAA) financials

NASDAQ · Health Care

$24.54 -2.77% Close Oct 30, 2026 Live

Staar Surgical revenue and earnings by year

Staar Surgical's revenue was $239 million in the fiscal year to January 2, 2026, down 23.7% from the year before. Net income was -$80.4 million, -33.6% of revenue. Since the fiscal year to December 30, 2016, revenue has grown 12.6% a year on average.

RevenueNet income
$0$200M
2016201720182020202120212022202320242026

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toJan 2026Dec 2024Dec 2023Dec 2022Dec 2021Jan 2021Jan 2020Dec 2018Dec 2017Dec 2016
Revenue2393143222842301631501249182
Revenue growth-23.7%-2.6%13.4%23.4%41.0%8.8%21.2%36.8%9.9%—
Gross profit182240253223179118112926458
Gross margin76.2%76.3%78.4%78.5%77.5%72.4%74.5%73.8%70.9%70.8%
Operating income-92-132844337127-4-13
Operating margin-38.3%-4.0%8.7%15.4%14.5%4.1%7.9%5.3%-4.0%-15.4%
Net income-80-202140286145-2-12
Net margin-33.6%-6.4%6.6%13.9%11.9%3.6%9.4%4.0%-2.4%-14.7%
Diluted EPS-$1.62-$0.41$0.43$0.80$0.56$0.12$0.30$0.10-$0.05-$0.29
Free cash flow-40-8-418301316112-2

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open STAA in Markets.

See also: STAA valuation and P/E history · STAA returns

No forecast, no recommendation. This page describes Staar Surgical from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.